Combat Group
  • Home
  • Healthcare Professionals
    • Urology
      • Clinical Evidence
      • BRS HIVEC Systems
      • Training Resources
      • HIVEC Clinical Trials
    • Surgical Oncology
      • Clinical Evidence
      • PRS+ HIPEC System
      • Training Resources
      • HIPEC Clinical Trials
  • Products
    • BRS HIVEC (Bladder Cancer)
    • PRS HIPEC (Peritoneal Cancers)
  • Patient Support
    • Bladder Cancer Patients HIVEC
    • Bladder Cancer Patients HIVEC Deutsch
    • Surgical Oncology Patients HIPEC
  • Global Partners
    • BRS HIVEC Distributors
    • PRS HIPEC Distributors
  • About Us
    • Company
    • News Feed
    • Investors
    • Team
      • Advisory Board
      • Board and Senior Management Team
    • Contact
  • Our Blog
  • en EN
    • en EN
    • es ES
Select Page
Another Study Showing HIVEC’s Efficacy in HR Bladder Cancer

Another Study Showing HIVEC’s Efficacy in HR Bladder Cancer

by Combat Cancer | Nov 2, 2023 | News

Breaking news! A new study just published in International Urology and Nephrology (Pazir et al) demonstrates that HIVEC with mitomycin C has a similar oncological efficacy and safety profile to standard BCG therapy in high-risk, non-muscle-invasive bladder cancer...
Next Entries »

Recent Posts

  • “SampleCam” – Could This Tiny Robotic Device Be An Alternative To Invasive Colonoscopies For High-Risk Patients?
  • Genetics and Bowel Cancer Risk
  • Combat’s Upcoming HIVEC®-HEAT Study 2025
  • The Estimated Lifetime Risk of Being Diagnosed With Ovarian Cancer
  • HIVEC®-HEAT Phase 3 Trial Receives Ethical and MHRA Approval

Recent Comments

    Archives

    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • July 2023
    • January 2023
    • December 2022
    • August 2022
    • May 2022
    • April 2022
    • March 2022

    Categories

    • Hyperthermia
    • News
    • The Medical Innovators Interview
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Stay informed about the COMBAT Group
    For more information contact: Combat Medical Group
    UK (+44) 1582 343 120 | Spain (+34) 910 46 89 71
    Privacy statement